No Data
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Assertio to Participate in the IAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025
Assertio Holdings Is Maintained at Buy by HC Wainwright & Co.
Assertio Holdings Analyst Ratings
Express News | Assertio Holdings, Inc. : H.c. Wainwright Cuts Target Price to $3.5 From $4
New Analyst Forecast: $ASRT Given $1.75 Price Target
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
White_Shadow : what/where you aquire this info?
White_Shadow : Do you mean reverse split???